- Filed
- May 7, 2021 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2021 · Apr 30, 2021 | 34.08M sh |
| Stock Repurchased | Q1 2021 · Mar 31, 2021 | $0 |
| Stock Repurchased | Q1 2021 · Mar 31, 2020 | $10.5M |
| Long Term Debt | Q1 2021 · Mar 31, 2021 | $0 |
| Long Term Debt | Q1 2021 · Dec 31, 2020 | $5.84M |
| Short Term Debt | Q1 2021 · Mar 31, 2021 | $36.52M |
| Short Term Debt | Q1 2021 · Dec 31, 2020 | $50M |
| Cash And Equivalents | Q1 2021 · Mar 31, 2021 | $80.55M |
| Cash And Equivalents | Q1 2021 · Dec 31, 2020 | $82.08M |
| Cash And Equivalents | Q1 2021 · Mar 31, 2020 | $107.02M |
| Cash And Equivalents | Q1 2021 · Dec 31, 2019 | $63.3M |
| Current Liabilities | Q1 2021 · Mar 31, 2021 | $136.48M |
| Current Liabilities | Q1 2021 · Dec 31, 2020 | $145.75M |
| Total Liabilities | Q1 2021 · Mar 31, 2021 | $172.44M |
| Total Liabilities | Q1 2021 · Dec 31, 2020 | $189.3M |
| Current Assets | Q1 2021 · Mar 31, 2021 | $265.82M |
| Current Assets | Q1 2021 · Dec 31, 2020 | $271.7M |
| Total Assets | Q1 2021 · Mar 31, 2021 | $581.37M |
| Total Assets | Q1 2021 · Dec 31, 2020 | $600.39M |
| Shares Diluted | Q1 2021 · Mar 31, 2020 | 33.8M sh |
| Capex | Q1 2021 · Mar 31, 2020 | $3.58M |
| Operating Cash Flow | Q1 2021 · Mar 31, 2020 | $17.36M |
| Stockholders Equity | Q1 2021 · Mar 31, 2020 | $398.15M |
| Stockholders Equity | Q1 2021 · Dec 31, 2019 | $416.12M |
| Eps Diluted | Q1 2021 · Mar 31, 2020 | −$0.11 |
| Eps Basic | Q1 2021 · Mar 31, 2020 | −$0.11 |
| Sga Expense | Q1 2021 · Mar 31, 2020 | $13.18M |
| Rd Expense | Q1 2021 · Mar 31, 2020 | $17.57M |
| Net Income | Q1 2021 · Mar 31, 2020 | −$3.6M |
| Operating Income | Q1 2021 · Mar 31, 2020 | −$3.23M |
| Gross Profit | Q1 2021 · Mar 31, 2020 | $62.78M |
| Revenue | Q1 2021 · Mar 31, 2020 | $109.38M |